Leadership Administrative Core - LAC
领导行政核心 - LAC
基本信息
- 批准号:10213169
- 负责人:
- 金额:$ 20.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeBiologicalCommunitiesDevelopmentEducational CurriculumEducational process of instructingEnsureEvaluationFacultyGenderGenesGoalsGovernmentGrowthHormonesImmune responseImmunityImmunologyInfluenzaInformation DisseminationInternationalLeadershipLife Cycle StagesLinkMediatingMentorsMicrobiologyMolecularPlayPrincipal InvestigatorProfessional OrganizationsProtocols documentationPublic Health SchoolsPublicationsResearchResearch PersonnelResearch Project GrantsRoleSex DifferencesSocietiesStructureUniversitiesVaccinesWomen&aposs Healthage differencecareerdata disseminationfrailtyinfluenza virus vaccinemedical schoolsmeetingsprogramssexskillssocial mediasymposiumweb site
项目摘要
SEX AND AGE DIFFERENCES IN IMMUNITY TO INFLUENZA (SADII) LEADERSHIP
ADMINISTRATIVE CORE SUMMARY
The primary goal of the SCORE on Sex and Age Differences in Immunity to Influenza (SADII) is to
systematically evaluate sex differences in vaccine-induced immune responses across the life course, with
consideration of the role that hormones, genes, age, and frailty play as independent and combined mediating
factors. The primary objective of the SADII Leadership Administrative Core (LAC) is to provide centralized
management, leadership, rigor, sharing, and dissemination of the data from the proposed Research Projects
and Cores in the SADII SCORE. This objective will be met by accomplishing three specific aims. Aim 1 will be
to provide a centralized, structured administration for all SADII SCORE investigators. The SADII SCORE will
be physically housed within the Department of Molecular Microbiology and Immunology (MMI) at the Johns
Hopkins Bloomberg School of Public Health and through the SADII Career Enhancement Core, will be
integrated with the Johns Hopkins BIRCWH program and the Johns Hopkins Center for Women’s Health, Sex,
and Gender Research (JH-CWHSGR). Aim 2 will be to provide scientific leadership for the SADII SCORE
program. The SADII LAC will ensure rigor in the research conducted, dissemination of the research results to
the greater scientific community, mentoring of junior faculty new to the study of sex as a biological variable,
and integration of the SADII SCORE into the conceptual framework and teachings at Johns Hopkins
University. Aim 3 of the SADII LAC will seek to enhance dissemination of research findings from the SADII
SCORE to the Johns Hopkins research community, broader scientific community, and governmental decision
bodies determining influenza vaccine strains and platforms. Dissemination of research findings from the SADII
SCORE will involve diverse platforms, including, but not limited to: 1) presentation and dissemination of results
at the annual JH-CWHSGR symposium, national and international meetings of professional societies, and the
annual meeting of the Organization for the Study of Sex Differences, which is an international research society,
for which Dr. Sabra Klein is President (2018-2020); 2) embedding the concept of sex as a biological variable
into the Johns Hopkins graduate and medical school curriculum; 3) establishment of a rigorous publication plan
that will ensure that publications of research, ideas, and information derived from the SADII SCORE will
appropriately acknowledge SADII for its contribution; 4) development of an informational website for the SADII
SCORE that links to other related websites both within and outside of Johns Hopkins; and 5) social media
engagement for immediate dissemination of SADII research, presentations, and activities. The Program
Director (Dr. Sabra Klein) and Co-Director (Dr. Patricia Gearhart) have the research expertise and leadership
skills to ensure that the overarching goals of the SADII SCORE are met and exceeded.
流感免疫力 (SADII) 领导力的性别和年龄差异
行政核心概要
流感免疫力性别和年龄差异评分 (SADII) 的主要目标是
系统地评估整个生命过程中疫苗诱导的免疫反应的性别差异,
考虑激素、基因、年龄和虚弱作为独立和联合中介的作用
SADII 领导行政核心 (LAC) 的主要目标是提供集中化的服务。
拟议研究项目数据的管理、领导、严谨、共享和传播
SADII SCORE 中的核心将通过实现三个具体目标来实现。
为所有 SADII SCORE 调查员提供集中、结构化的管理。
实际位于约翰斯大学分子微生物学和免疫学系 (MMI) 内
霍普金斯大学彭博公共卫生学院并通过 SADII 职业增强核心,将
与约翰·霍普金斯大学 BIRCWH 计划和约翰·霍普金斯大学妇女健康、性、
目标 2 是为 SADII SCORE 提供科学领导。
SADII LAC 将确保研究的严谨性,并将研究结果传播给
更大的科学界,对刚接触性别作为生物变量研究的初级教师进行指导,
并将 SADII SCORE 纳入约翰霍普金斯大学的概念框架和教学
大学。SADII LAC 的目标 3 将寻求加强 SADII 研究成果的传播。
为约翰霍普金斯大学研究界、更广泛的科学界和政府决策评分
确定流感疫苗株和平台的机构传播 SADII 的研究成果。
SCORE将涉及多种平台,包括但不限于:1)结果的呈现和传播
在年度 JH-CWHSGR 研讨会、专业协会的国内和国际会议以及
性别差异研究组织(一个国际研究协会)的年会,
Sabra Klein 博士担任主席(2018-2020)2)将性别概念嵌入生物变量;
纳入约翰·霍普金斯大学研究生和医学院课程;3)制定严格的出版计划;
这将确保源自 SADII SCORE 的研究、想法和信息的出版物
适当承认 SADII 的贡献;4) 为 SADII 开发信息网站
SCORE 链接到约翰·霍普金斯大学内部和外部的其他相关网站;5) 社交媒体;
参与立即传播 SADII 研究、演示和活动。
主任(Sabra Klein 博士)和联合主任(Patricia Gearhart 博士)拥有研究专业知识和领导力
确保达到并超越 SADII SCORE 总体目标的技能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SABRA L. KLEIN其他文献
SABRA L. KLEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SABRA L. KLEIN', 18)}}的其他基金
2023 Sex Differences in Immunity Gordon Research Conference
2023 年免疫性别差异戈登研究会议
- 批准号:
10721480 - 财政年份:2023
- 资助金额:
$ 20.88万 - 项目类别:
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
项目 3:定义 SARS-CoV-2 感染后的抗体格局
- 批准号:
10221910 - 财政年份:2020
- 资助金额:
$ 20.88万 - 项目类别:
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
项目 3:定义 SARS-CoV-2 感染后的抗体格局
- 批准号:
10688368 - 财政年份:2020
- 资助金额:
$ 20.88万 - 项目类别:
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
项目 3:定义 SARS-CoV-2 感染后的抗体格局
- 批准号:
10221910 - 财政年份:2020
- 资助金额:
$ 20.88万 - 项目类别:
Sex and Age Differences in Immunity to Influenza (SADII)
流感免疫力的性别和年龄差异 (SADII)
- 批准号:
10460494 - 财政年份:2018
- 资助金额:
$ 20.88万 - 项目类别:
Genetic and hormonal mechanisms of sex differences in immune responses and influenza vaccine efficacy in young and aged mice
年轻和老年小鼠免疫反应和流感疫苗功效性别差异的遗传和激素机制
- 批准号:
10460499 - 财政年份:2018
- 资助金额:
$ 20.88万 - 项目类别:
相似国自然基金
基于生物多样性提升的严寒地区城市社区空间形态优化路径研究
- 批准号:52308059
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于“风温伏肺”理论探讨清肺透邪方对支原体肺炎CARDS毒素损伤的保护机制研究
- 批准号:81774363
- 批准年份:2017
- 资助金额:57.0 万元
- 项目类别:面上项目
西部重点生态功能区农村社区参与旅游发展的途径、减贫机制与可持续发展研究:以陕南为例
- 批准号:71573205
- 批准年份:2015
- 资助金额:50.0 万元
- 项目类别:面上项目
高黎贡山自然保护区周边局域社会生态系统研究
- 批准号:31060077
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:地区科学基金项目
卧龙自然保护区社区居民行为与生物多样性保护耦合分析
- 批准号:40801220
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 20.88万 - 项目类别:
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
停止使用羟氯喹治疗老年狼疮病 (SHIELD)
- 批准号:
10594743 - 财政年份:2023
- 资助金额:
$ 20.88万 - 项目类别:
Proteomic and epigenetic alterations associated with plant-based diets and CVD
与植物性饮食和心血管疾病相关的蛋白质组学和表观遗传改变
- 批准号:
10643149 - 财政年份:2023
- 资助金额:
$ 20.88万 - 项目类别:
A multi-omic and integrative longitudinal evaluation of the role of lipid, antioxidant, and osmoprotectant metabolites in the genitourinary syndrome of menopause by race and ethnicity.
按种族和民族对脂质、抗氧化剂和渗透保护代谢物在更年期泌尿生殖综合征中的作用进行多组学和综合纵向评估。
- 批准号:
10643444 - 财政年份:2023
- 资助金额:
$ 20.88万 - 项目类别: